Analystreport

Innovate Biopharmaceuticals Inc (NASDAQ: INNT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

INNOVATE BIOPHARMACEUTICALS  (INNT) 
Last innovate biopharmaceuticals earnings: 8/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.innovatebiopharma.com/news-releases